These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6266112)
1. [Detection of a stromal luteoma of the ovary using 131I-iodocholesterol scintigraphy]. Taillefer R; Levasseur A; Chapdelaine A; Bélanger AB Union Med Can; 1981 May; 110(5):435-8. PubMed ID: 6266112 [No Abstract] [Full Text] [Related]
2. Leydig-cell tumor of the ovary: visualization using 131I-19-iodocholesterol scintigraphy. Glaser B; Weill S; Lurie M; Kahana L; Abramovici H; Sheinfeld M Eur J Nucl Med; 1985; 11(1):13-6. PubMed ID: 4043108 [TBL] [Abstract][Full Text] [Related]
3. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases. Taillefer R; Soucy JP; Eybalin MC; Levasseur A J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882 [TBL] [Abstract][Full Text] [Related]
4. The role of 131I-19-iodocholesterol scintigraphy and ultrasonography in the localization of a poorly vascularized phaeochromocytoma. Troncone L; Falappa PG; Cavallaro A; Netri G Br J Radiol; 1981 Apr; 54(640):353-5. PubMed ID: 7225727 [No Abstract] [Full Text] [Related]
5. [Improvement in the quality of 19-iodocholesterol-131I scintigraphy by using polysponin]. Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA Med Radiol (Mosk); 1980 Sep; 25(9):14-8. PubMed ID: 7421434 [No Abstract] [Full Text] [Related]
6. [Evaluation of the reliability of 131I-19-iodocholesterol scintigraphic examination in the diagnosis of adrenal tumors]. Troncone L; Galli G; Focacci C Radiol Med; 1980 Nov; 66(11):841-2. PubMed ID: 7221053 [No Abstract] [Full Text] [Related]
7. [Dissociation between absorption of 131I-19-iodocholesterol and hormonal activity in corticosteroma patients]. Burliev G; Koev D; Zlatareva N; Khubaveshki S Vutr Boles; 1987; 26(3):88-91. PubMed ID: 3617712 [TBL] [Abstract][Full Text] [Related]
8. Concentration of radiolabeled cholesterol in a feminizing adenoma of the testis. Leonard JM; Rudd TG; Burgess EC; Monda GA J Nucl Med; 1979 Apr; 20(4):307-9. PubMed ID: 536808 [TBL] [Abstract][Full Text] [Related]
9. [Role of adrenal 131-I-19-iodocholesterol scintigraphy in the etiological diagnosis of primary hyperaldosteronism]. Rodat O; Charbonnel B; Lucas B; Weber M; Donet P; Mitard D; Tellier JL Rev Med Interne; 1982; 3(3):257-61. PubMed ID: 7178715 [No Abstract] [Full Text] [Related]
10. [Use of pharmacological preparations for the purpose of improving the visualization of the adrenals with 19-iodocholesterol-131I]. Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA Med Radiol (Mosk); 1979 Jan; 24(1):37-41. PubMed ID: 215865 [No Abstract] [Full Text] [Related]
11. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)]. Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332 [TBL] [Abstract][Full Text] [Related]
19. [Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats]. Ito T; Ogawa H; Maeda M; Kojima M Yakugaku Zasshi; 1983 Jun; 103(6):644-9. PubMed ID: 6655551 [No Abstract] [Full Text] [Related]
20. [Scintigraphy of the adrenals using 19-iodocholesterol-131I]. Zubovskiĭ GA; Turaev RN; Marova EI Med Radiol (Mosk); 1978 Jan; 23(1):45-9. PubMed ID: 342859 [No Abstract] [Full Text] [Related] [Next] [New Search]